Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · Real-Time Price · USD
24.06
+0.84 (3.62%)
At close: Jul 2, 2025, 4:00 PM
24.08
+0.02 (0.08%)
After-hours: Jul 2, 2025, 7:33 PM EDT
Janux Therapeutics Market Cap
Janux Therapeutics has a market cap or net worth of $1.42 billion as of July 2, 2025. Its market cap has decreased by -35.19% in one year.
Market Cap
1.42B
Enterprise Value
432.22M
1-Year Change
-35.19%
Ranking
Category
Stock Price
$24.06
Market Cap Chart
Since the IPO on June 11, 2021, Janux Therapeutics's market cap has increased from $613.73M to $1.42B, an increase of 131.99%. That is a compound annual growth rate of 23.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2025 | 1.37B | -55.49% |
| Dec 31, 2024 | 3.09B | 523.34% |
| Dec 29, 2023 | 495.20M | -9.51% |
| Dec 30, 2022 | 547.22M | -33.35% |
| Dec 31, 2021 | 821.00M | 33.77% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 697.99B |
| Johnson & Johnson | 374.53B |
| AbbVie | 337.98B |
| Novo Nordisk | 306.99B |
| UnitedHealth Group | 284.07B |
| Novartis AG | 242.04B |
| Abbott Laboratories | 233.96B |
| AstraZeneca | 219.33B |